Collaboration Framework Agreement Between the Technion and Pfizer Signed to Accelerate Scientific Breakthroughs
Technion-Israel Institute of Technology and Pfizer, one of the world’s premier biopharmaceutical companies, recently signed a collaboration framework agreement to identify opportunities to collaborate and bring forward scientific breakthroughs at the interface between artificial intelligence and drug development. The framework agreement was finalized during the…